Skip to main content
MLYS filings

Corporate insider profile

David Malcom Rodman Filing Activity

Latest reported as Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,782,071.07
Latest transaction
Jun 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale14,474$24.19$350,087
Jun 12, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale8,519$24.20$206,151
May 18, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale417$27.55$11,488